Late-demographic dividend vs Oman: Immunization, measles
Late-demographic dividend
94.6%
in 2024
Oman
99.0%
in 2024
Late-demographic dividend rank
4th
Oman rank
1st
Immunization, measles over time
- Late-demographic dividend
- Oman
How they compare
Oman currently reports 99.0% against 94.6% in Late-demographic dividend, a difference of 4.4%.
The two have swapped places 4 times across 45 shared years of data; in 1980 it was Oman ahead.
Late-demographic dividend ranks 4th and Oman ranks 1st of 47 groups.
Across the 5 decades both report, Late-demographic dividend averaged higher in 1 and Oman in 4.
Head to head by decade
| Decade | Late-demographic dividend | Oman | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 55.7% | 55.4% | 0.3% | Late-demographic dividend |
| 1990s | 86.3% | 97.3% | 11.0% | Oman |
| 2000s | 92.1% | 98.1% | 6.0% | Oman |
| 2010s | 97.8% | 99.0% | 1.2% | Oman |
| 2020s | 94.2% | 98.6% | 4.4% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, Late-demographic dividend or Oman?
- Oman, at 99.0% against 94.6% in Late-demographic dividend as of 2024.
- What is the difference in immunization, measles between Late-demographic dividend and Oman?
- 4.4%, with Oman ahead.
- How many years of comparable data are there for Late-demographic dividend and Oman?
- 45 years are reported by both, from 1980 to 2024.
- How do Late-demographic dividend and Oman rank globally for immunization, measles?
- Late-demographic dividend ranks 4th and Oman ranks 1st of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.